Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4. - Wikidata - awgldk - TriplyDB

Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.

Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.

http://www.wikidata.org/entity/Q33780620

about

P6981, An Arylstibonic Acid, Is a Novel Low Nanomolar Inhibitor of cAMP Response Element-Binding Protein Binding to DNA Scaffold optimization in discontinuous epitope containing protein mimics of gp120 using smart libraries.Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor.Potent antiviral activity of north-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus.A combinatorial approach toward smart libraries of discontinuous epitopes of HIV gp120 on a TAC synthetic scaffold.Single DNA molecule stretching measures the activity of chemicals that target the HIV-1 nucleocapsid protein.HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity.Extracts from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and Tat.Potent inhibition of human apurinic/apyrimidinic endonuclease 1 by arylstibonic acids.Zinc finger proteins as templates for metal ion exchange and ligand reactivity. Chemical and biological consequences.The Potential of Sub-Saharan African Plants in the Management of Human Immunodeficiency Virus Infections: A Review.Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.Antiviral propierties of 5,5'-dithiobis-2-nitrobenzoic acid and bacitracin against T-tropic human immunodeficiency virus type 1.Mode of antiviral action of silver nanoparticles against HIV-1.Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection.Effects of macromolecular crowding on the inhibition of virus assembly and virus-cell receptor recognition.Selective Tropism of Dengue Virus for Human Glycoprotein Ib.Antibody-Mediated Therapy against HIV/AIDS: Where Are We Standing Now?

P2860

Q27671025-1CF5B024-8AD0-4912-B47C-1CE67E6AB24A Q31112205-1864D559-CF93-49CF-9C8C-6FD92B2B9DA5 Q33223969-6A2E4735-E03E-495E-B167-FCB5DE8E5A87 Q34228263-D4851B79-0E9B-499C-BED8-D41D67FCC737 Q34398542-0CBBC73D-B5B7-4116-8E5D-DA2E3DFF859B Q35166620-75A89023-0926-4B75-80CB-8568F4C93390 Q35542610-838D6D53-FB5E-4B0F-81FB-D7101854E989 Q36364955-8B565324-D3DE-493B-8EC5-DD8D2B94FFC1 Q37285671-3090D048-D505-4554-B73F-01B9D70C8027 Q37288467-D82D6AA0-22A2-4987-B87A-8BB4E459412A Q37831171-C3034417-CE6A-4674-8515-A9D5166F636D Q38580320-26C23E78-B75C-4269-B054-68D07B45B22C Q38816992-D30310B1-BF6E-4EC0-9500-441520E3845E Q39160523-CBFD424D-00DD-4F4B-AC19-5D52893FFB45 Q39160530-C2089705-B6F8-44A5-AB39-28AF7F350271 Q39214842-3BF29FF9-C803-49B7-8D98-C9023FD297A8 Q39600262-1802F923-49FC-465C-ADCF-9A89C3A2D34A Q50091170-4D52969B-04FE-4AE3-AE56-90669CE28A41 Q55436995-E152325C-86B7-4394-B8B9-73501269F1EE

P2860

Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.

http://www.wikidata.org/entity/Q33780620

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Discovery of small-molecule hu ...... e gp120-binding domain of CD4.

@ast

Discovery of small-molecule hu ...... e gp120-binding domain of CD4.

@en

type

label

Discovery of small-molecule hu ...... e gp120-binding domain of CD4.

@ast

Discovery of small-molecule hu ...... e gp120-binding domain of CD4.

@en

prefLabel

Discovery of small-molecule hu ...... e gp120-binding domain of CD4.

@ast

Discovery of small-molecule hu ...... e gp120-binding domain of CD4.

@en

P1433

Q33780620-D89806AD-33D6-44DF-A6A1-32720A867428

P1476

Q33780620-6578B814-0385-4CD3-8AAD-3712915F77C0

P2093

Q33780620-0BDFF852-002D-4A3F-A031-7647886ACF80

Q33780620-1BC59271-9FDD-4C20-A843-7A2658C90759

Q33780620-21A2B2F6-CC58-40A7-8D73-8CE53C1D2421

Q33780620-22CC2625-4FC8-4977-8C03-B4FE32D50B8F

Q33780620-2629B52F-68DA-42DB-9AA0-9A5161833A82

Q33780620-33CD716D-1C04-4508-B8A1-4545275C9C5D

Q33780620-3C4A731A-0AE1-4545-AB4C-799F8F6E79EE

Q33780620-641B93B9-AD08-42A3-9AD5-AC022F385673

Q33780620-D08FEEF9-D7F8-49F5-A316-751E54547AEB

Q33780620-D15F77B8-4D49-449B-BAA2-FFEE5D4D93AE

P2860

Q33780620-16069012-6766-45DB-B4B5-98180C51B369

Q33780620-1B669A47-B136-4BE1-A05F-77354A84F030

Q33780620-1BAE0AAA-35CF-4B1A-BD96-E904649E5036

Q33780620-1D91B404-1125-425B-A0C0-3DDE3EC9C7F2

Q33780620-20CBF230-E922-4C19-B482-A1D2A39DBED9

Q33780620-237A4CA6-A7B2-492A-AB8E-4D6A1E6DA620

Q33780620-2944392F-263A-48C8-96E8-0BAC46993E06

Q33780620-2A9BC9C0-82CA-451D-BBBF-723854329840

Q33780620-32E59608-DA6D-488B-A0D5-D3B9D06CFABF

Q33780620-39D36CDC-5EAF-4C5E-A79C-6819A326B924

P304

Q33780620-76D8D728-1E0B-47A3-947A-6D8E3ABDD641

P31

Q33780620-9CC72E63-8882-4185-954E-F825F1DBA75A

P356

Q33780620-25BF8D77-99C5-44AE-8432-7B49F49BDD33

P433

Q33780620-67BCBAAA-466E-4952-9A6B-2A1D67AF6386

P478

Q33780620-05CA6744-3536-43EF-BCC8-9315FE41A466

P50

Q33780620-08A4CC29-7546-443A-AC15-3E685A30228C

P577

Q33780620-0774B97C-3E03-49EA-89C2-8EFA30E9533D

P5875

Q33780620-D6FB0E17-8B9B-493D-B34C-FB5E3F7DFF58

P698

Q33780620-0CF2E6AF-90B3-46F2-8C95-2E9C5F93AD06

P932

Q33780620-B23315DF-B8CF-4287-80A8-24AC5A5EBBF1

P356

JVI.79.10.6122-6133.2005

P1433

Journal of Virology

P1476

Discovery of small-molecule hu ...... e gp120-binding domain of CD4.

@en

P2093

Alan R Rein

http://www.w3.org/2001/XMLSchema#string

Andrew G Stephen

http://www.w3.org/2001/XMLSchema#string

Bruce J Crise

http://www.w3.org/2001/XMLSchema#string

Joseph W Adelsberger

http://www.w3.org/2001/XMLSchema#string

Michael J Currens

http://www.w3.org/2001/XMLSchema#string

Paula E Roberts

http://www.w3.org/2001/XMLSchema#string

Quan-En Yang

http://www.w3.org/2001/XMLSchema#string

Robert H Shoemaker

http://www.w3.org/2001/XMLSchema#string

Robert J Fisher

http://www.w3.org/2001/XMLSchema#string

Shizuko Sei

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket

Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

Core structure of gp41 from the HIV envelope glycoprotein

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors

Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication

Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight

P304

6122-6133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.79.10.6122-6133.2005

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Robert J Gorelick

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7880090

http://www.w3.org/2001/XMLSchema#string

P698

15857997

http://www.w3.org/2001/XMLSchema#string

P932

1091715

http://www.w3.org/2001/XMLSchema#string